Researchers have made a significant discovery regarding the brain's influence on high blood pressure, focusing on a specific area known as the lateral parafacial region. This region, located in the brainstem, is integral to managing automatic bodily functions, including breathing and heart rate.
Lead researcher Professor Julian Paton, who heads the Manaaki Manawa Centre for Heart Research at Waipapa Taumata Rau, University of Auckland, explains, "The lateral parafacial region activates during activities such as laughing, exercising, or coughing, prompting us to exhale forcefully." This process engages the abdominal muscles, contrasting with regular exhalation, which occurs passively due to lung elasticity.
Link Between Breathing and Blood Pressure
The research team discovered that this brain area is connected to nerves that constrict blood vessels, thereby raising blood pressure. "We've identified a previously unknown brain region that contributes to high blood pressure," Paton asserts. "In conditions of hypertension, the lateral parafacial region becomes active; however, when we deactivated it, blood pressure returned to normal levels."
This revelation indicates that specific breathing techniques, particularly those utilizing strong abdominal muscles, may elevate blood pressure. By recognizing these patterns in individuals with hypertension, healthcare providers can better understand the underlying causes and tailor treatments accordingly.
The findings were published in the journal Circulation Research.
Exploring New Treatment Avenues
Could this brainstem region be a viable target for treatment? The researchers investigated the potential for medication to influence this area. "Administering drugs that affect the entire brain complicates targeting specific regions like the parafacial nucleus," Paton notes.
A pivotal advancement emerged when the team found that the lateral parafacial region is activated by external signals from the carotid bodies--small cell clusters in the neck that regulate blood oxygen levels. This discovery opens up promising treatment possibilities, as the carotid bodies can be safely targeted with medication.
"Our objective is to develop a drug that can safely inhibit carotid body activity, effectively reducing the activity of the lateral parafacial region without directly affecting the brain," Paton explains. This innovative approach could revolutionize hypertension treatment, particularly for individuals suffering from sleep apnea, where carotid body activity escalates during breathing interruptions at night.